|
Q4 2023
|
168 |
570,787 |
PFMT, NATR, IWM, CVEO
|
13F-HR
|
2/12/2024 |
000108514624001029 |
|
Q3 2023
|
159 |
451,222 |
PFMT, NATR, ATSG, CVEO
|
13F-HR
|
11/13/2023 |
000108514623004249 |
|
Q2 2023
|
162 |
455,936 |
PFMT, NATR, ATSG, CVEO
|
13F-HR
|
8/10/2023 |
000108514623003237 |
|
Q1 2023
|
165 |
428,443 |
PFMT, NATR, CVEO, FCFS
|
13F-HR
|
5/10/2023 |
000108514623002208 |
|
Q4 2022
|
183 |
458,896 |
PFMT, CVEO, NATR, FTI
|
13F-HR
|
2/10/2023 |
000108514623001053 |
|
Q3 2022
|
142 |
324,187 |
PFMT, CVEO, NATR, FTI
|
13F-HR
|
11/10/2022 |
000131586322000751 |
|
Q2 2022
|
152 |
374,113 |
PFMT, CVEO, NATR, MDY
|
13F-HR
|
8/12/2022 |
000131586322000558 |
|
Q1 2022
|
140 |
390,987 |
PFMT, CVEO, NATR, SKX
|
13F-HR
|
5/10/2022 |
000131586322000363 |
|
Q4 2021
|
186 |
440,839 |
PFMT, NATR, EDU, CVEO
|
13F-HR
|
2/10/2022 |
000131586322000098 |
|
Q3 2021
|
150 |
364,150 |
PFMT, CVEO, NATR, EDU
|
13F-HR
|
11/10/2021 |
000131586321000871 |
|
Q2 2021
|
131 |
353,652 |
PFMT, MDY, CVEO, NATR
|
13F-HR
|
8/10/2021 |
000131586321000656 |
|
Q1 2021
|
134 |
342,020 |
MDY, NATR, PFMT, CVEO
|
13F-HR
|
5/10/2021 |
000131586321000423 |
|
Q4 2020
|
101 |
345,566 |
MDY, NATR, IWM, CDEV
|
13F-HR
|
2/10/2021 |
000131586321000159 |
|
Q3 2020
|
102 |
224,746 |
NATR, PFMT, NVR, UEPS
|
13F-HR
|
11/13/2020 |
000131586320000922 |
|
Q2 2020
|
91 |
202,233 |
NATR, RTLR, PFMT, UEPS
|
13F-HR
|
8/10/2020 |
000131586320000683 |
|
Q1 2020
|
107 |
201,658 |
NATR, PFMT, UEPS, ENVA
|
13F-HR
|
5/13/2020 |
000131586320000443 |
|
Q4 2019
|
134 |
288,875 |
NATR, UEPS, SLCA, ENVA
|
13F-HR
|
2/7/2020 |
000131586320000132 |
|
Q3 2019
|
143 |
325,356 |
NATR, UEPS, ATSG, CURO
|
13F-HR
|
11/13/2019 |
000131586319000909 |
|
Q2 2019
|
157 |
410,650 |
ENVA, NATR, UEPS, DBD
|
13F-HR
|
8/9/2019 |
000131586319000670 |
|
Q1 2019
|
160 |
488,272 |
ENVA, DBD, NATR, CIVEO CORP CDA
|
13F-HR
|
5/10/2019 |
000131586319000439 |
|
Q4 2018
|
214 |
510,958 |
UEPS, CDXS, ENVA, NATR
|
13F-HR
|
2/11/2019 |
000131586319000143 |
|
Q3 2018
|
203 |
510,404 |
UEPS, ENVA, CDXS, ATSG
|
13F-HR
|
11/9/2018 |
000131586318000850 |
|
Q2 2018
|
209 |
532,415 |
ENVA, ATSG, NATR, CIVEO CORP CDA
|
13F-HR
|
8/13/2018 |
000131586318000630 |
|
Q1 2018
|
195 |
459,943 |
ENVA, NATR, ATSG, UEPS
|
13F-HR
|
5/7/2018 |
000131586318000417 |
|
Q4 2017
|
178 |
482,726 |
ATSG, ENVA, NATR, CDXS
|
13F-HR
|
2/7/2018 |
000131586318000127 |
|
Q3 2017
|
158 |
490,520 |
ATSG, ENVA, NATR, CIVEO CORP CDA
|
13F-HR
|
11/13/2017 |
000131586317000856 |
|
Q2 2017
|
163 |
476,988 |
ATSG, ENVA, NATR, SREV
|
13F-HR
|
7/20/2017 |
000131586317000586 |
|
Q1 2017
|
168 |
457,745 |
ATSG, ENVA, NATR, CIVEO CORP CDA
|
13F-HR
|
5/1/2017 |
000131586317000398 |
|
Q4 2016
|
159 |
475,240 |
ATSG, NATR, ENVA, SREV
|
13F-HR
|
1/27/2017 |
000131586317000063 |
|
Q3 2016
|
146 |
468,691 |
ATSG, NATR, PHARMATHENE INC, ENVA
|
13F-HR
|
10/28/2016 |
000131586316001862 |
|
Q2 2016
|
139 |
415,232 |
ATSG, PHARMATHENE INC, NATR, SREV
|
13F-HR
|
7/21/2016 |
000131586316001629 |
|
Q1 2016
|
140 |
420,179 |
ATSG, NATR, SREV, PHARMATHENE INC
|
13F-HR
|
4/29/2016 |
000131586316001422 |
|
Q4 2015
|
159 |
435,921 |
ATSG, NATR, SREV, PHARMATHENE INC
|
13F-HR
|
1/26/2016 |
000131586316001061 |
|
Q3 2015
|
164 |
414,664 |
ATSG, NATR, SREV, DXLG
|
13F-HR
|
10/29/2015 |
000131586315000849 |
|
Q2 2015
|
183 |
502,632 |
ATSG, NATR, SREV, PHARMATHENE INC
|
13F-HR
|
8/10/2015 |
000131586315000651 |
|
Q1 2015
|
177 |
497,884 |
ATSG, NATR, RM, PHARMATHENE INC
|
13F-HR
|
4/27/2015 |
000131586315000380 |
|
Q4 2014
|
226 |
612,251 |
ATSG, NATR, SREV, BIOSCRIP INC
|
13F-HR
|
2/6/2015 |
000131586315000084 |
|
Q3 2014
|
199 |
506,829 |
ATSG, NATR, BIOSCRIP INC, PHARMATHENE INC
|
13F-HR
|
11/14/2014 |
000131586314000630 |
|
Q2 2014
|
213 |
568,445 |
ATSG, NATR, SREV, BIOSCRIP INC
|
13F-HR
|
7/17/2014 |
000131586314000454 |
|
Q1 2014
|
206 |
529,789 |
ATSG, NATR, BIOSCRIP INC, BLUEPHOENIX SOLUTIONS LTD
|
13F-HR
|
4/30/2014 |
000108514614000928 |
|
Q4 2013
|
200 |
526,350 |
ATSG, NATR, SILICON GRAPHICS INTL CORP, BIOSCRIP INC
|
13F-HR
|
2/12/2014 |
000108514614000519 |